Healthcare / Medical Care FacilitiesThailand
$16.50
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $497.0M · quality 78.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
43/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$13.0B
P/E
35.3x
↑EV/EBITDA
9.3x
↓ROE
14.0%
↑Gross Margin
36.6%
↓Debt/Equity
0.00
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+8.7%
FCF CAGR
-14.4%
FCF margin
8.7%
FCF / Net income
0.56x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $5.28B · net income $822.7M · FCF $458.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $5.28B | $5.28B | $4.64B | $4.20B | $4.11B |
| Net Income | $822.7M | $822.7M | $712.7M | $557.9M | $567.6M |
| EBITDA | $1.33B | $1.33B | $1.17B | $988.2M | $1.00B |
| EPS | — | — | 0.91 | 0.71 | 0.72 |
| Gross Margin | 36.6% | 36.6% | 34.3% | 32.9% | 33.7% |
| Operating Margin | 17.9% | 17.9% | 17.1% | 15.4% | 16.5% |
| Net Margin | 15.6% | 15.6% | 15.4% | 13.3% | 13.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 3.77 | 3.77 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $458.3M | $458.3M | $790.6M | $497.0M | $729.5M |
| Returns | |||||
| ROE | 14.0% | 14.0% | 13.1% | 11.0% | 12.0% |
| Valuation | |||||
| P/E | 35.26 | 35.26 | — | — | — |
| EV/EBITDA | 9.29 | 9.29 | — | — | — |
| P/B | 2.21 | 2.21 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 13.8% | 13.8% | 10.3% | 2.3% | — |
| EPS Growth | — | — | 28.2% | -1.4% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+0.0%
Start / end P/E
n/dx → n/dx
EPS bridge
0.91 → n/d
Residual
+0.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.